Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 04 Jul 2024

Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml

in Pharmacology of Anti-Cancer Drugs

Lei Ren
Yanling Chen
Zixiong Liu
Guankai Huang
Weifeng Wang
Xu Yang
Baohua Bai
Yan Guo
Jian Ling
Xiaopeng Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1413953

1,209 views

Original Research

Published on 01 Jul 2024

Identification of a basement membrane-related gene signature for predicting prognosis, immune infiltration, and drug sensitivity in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Xiang Shengxiao
Sun Xinxin
Zhu Yunxiang
Tang Zhijie
Tang Xiaofei

Frontiers in Oncology

doi 10.3389/fonc.2024.1428176

1,947 views
1 citation

Mini Review

Published on 24 Jun 2024

EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring

in Pharmacology of Anti-Cancer Drugs

Yunlong Wang
Qinggui Qiu
Xuan Deng
Mengchao Wan

Frontiers in Oncology

doi 10.3389/fonc.2024.1426796

1,857 views
3 citations

Perspective

Published on 21 Jun 2024

Elemental biomapping of human tissues suggests toxic metals such as mercury play a role in the pathogenesis of cancer

in Pharmacology of Anti-Cancer Drugs

Roger Pamphlett
David P. Bishop

Frontiers in Oncology

doi 10.3389/fonc.2024.1420451

1,712 views
1 citation

Review

Published on 18 Jun 2024

Integrating Chinese medicine into mainstream cancer therapies: a promising future

in Pharmacology of Anti-Cancer Drugs

Baoyi Ni
Kaiyuan Xue
Jia Wang
Jilai Zhou
Lankang Wang
Xinmiao Wang
Ting Liu
Naijing Ye
Jiakang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1412370

2,676 views
3 citations

Original Research

Published on 17 Jun 2024

Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients

in Pharmacology of Anti-Cancer Drugs

Jie Yang
Mengyu Zhang
Yilei Zhang
Lanfen Zhu
Qiming Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422117

929 views

Original Research

Published on 13 Jun 2024

Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors

in Pharmacology of Anti-Cancer Drugs

Qiu Xuan Tan
Nicholas B. Shannon
Weng Khong Lim
Jing Xian Teo
Daniel R. Y. Yap
Sze Min Lek
Joey W. S. Tan
Shih Jia J. Tan
Josephine Hendrikson
Ying Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1272432

1,181 views

Correction

Published on 03 Jun 2024

Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

in Pharmacology of Anti-Cancer Drugs

Ningning Yan
Sanxing Guo
Siyuan Huang
Huixian Zhang
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1412472

802 views

Methods

Published on 31 May 2024

ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery

in Pharmacology of Anti-Cancer Drugs

August J. John
Emily T. Ghose
Huanyao Gao
Meagan Luck
Dabin Jeong
Krishna R. Kalari
Liewei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1343091

1,361 views

Original Research

Published on 08 May 2024

The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study

in Pharmacology of Anti-Cancer Drugs

Yang Liu
Xianjun Liu
Binbin Xia
Jing Chen
Wenfang Sun
Fang Liu
Hua Cheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1230514

1,093 views

Original Research

Published on 01 May 2024

Electrochemical DNA-nano biosensor for the detection of Goserelin as anticancer drug using modified pencil graphite electrode

in Pharmacology of Anti-Cancer Drugs

Layla Abd-Al-Sattar Sadiq Laylani
F. Al-dolaimy
Ali Altharawi
Ghasen M. Sulaman
Mohammed Ahmed Mustafa
Adnan Taan Alkhafaji
Ali G. Alkhatami

Frontiers in Oncology

doi 10.3389/fonc.2024.1321557

4,482 views

Original Research

Published on 30 Apr 2024

In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation

in Pharmacology of Anti-Cancer Drugs

Shopnil Akash
Md. Rezaul Islam
Abdul Ali Bhuiyan
Mirza Nafeul Islam
Imren Bayıl
Rasha Mohammed Saleem
Ghadeer M. Albadrani
Muath Q. Al-Ghadi
Mohamed M. Abdel-Daim

Frontiers in Oncology

doi 10.3389/fonc.2024.1360745

3,210 views
3 citations

Review

Published on 30 Apr 2024

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer

in Pharmacology of Anti-Cancer Drugs

Marjorie A. Shapiro

Frontiers in Oncology

doi 10.3389/fonc.2024.1379738

6,116 views
8 citations

Original Research

Published on 25 Apr 2024

Body composition and inflammation variables as the potential prognostic factors in epithelial ovarian cancer treated with Olaparib

in Pharmacology of Anti-Cancer Drugs

Xingzi Guo
Jie Tang
Haifeng He
Lian Jian
Ouyang Qiang
Yongzhi Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1359635

1,585 views
2 citations

Review

Published on 23 Apr 2024

Cancer related cognitive impairment: a downside of cancer treatment

in Pharmacology of Anti-Cancer Drugs

Kimberly Demos-Davies
Jessica Lawrence
Davis Seelig

Frontiers in Oncology

doi 10.3389/fonc.2024.1387251

3,611 views
10 citations

Original Research

Published on 16 Apr 2024

Role of proteoglycan synthesis genes in osteosarcoma stem cells

in Pharmacology of Anti-Cancer Drugs

Ryoma Osumi
Kengo Sugihara
Makoto Yoshimoto
Kazuya Tokumura
Yuki Tanaka
Eiichi Hinoi

Frontiers in Oncology

doi 10.3389/fonc.2024.1325794

1,846 views
2 citations